4 Results for "

WDR5-IN-4

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "WDR5-IN-4" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-111753
CAS No.: 2407457-36-5
Purity:  98.13%
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

WDR5-IN-4 (Compound C6) is a WIN site inhibitor of chromatin-associated WD repeat domain 5 protein (WDR5), Kd The value is 0.1 nM. WDR5-IN-4 is able to displace WDR5 from chromatin and reduce the expression of related genes, causing translation inhibition and nucleolar stress. Has anti-cancer effects .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-111753A
CAS No.: 2749300-35-2
Purity:  99.87%
Target:  

WDR5 Apoptosis

Research Areas:  

Cancer

WDR5-IN-4 TFA (Compound C6) is an inhibitor of the WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5), with a Kd of 0.1 nM. WDR5-IN-4 TFA displaces WDR5 from chromatin and decreases the expression of associated genes, causing translational inhibition, nucleolar stress. Anti-cancer activity .
loading...
    loading...
Cat. No.: HY-111753AR
CAS No.: 2749300-35-2
Research Areas:  

Cancer

WDR5-IN-4 TFA (Standard) is the analytical standard of WDR5-IN-4 (TFA) (HY-111753A). This product is intended for research and analytical applications. WDR5-IN-4 TFA (Compound C6) is an inhibitor of the WIN site of chromatin-associated WD repeat-containing protein 5 (WDR5), with a Kd of 0.1 nM. WDR5-IN-4 TFA displaces WDR5 from chromatin and decreases the expression of associated genes, causing translational inhibition, nucleolar stress. Anti-cancer activity .
loading...
    loading...
Cat. No.: HY-184594
CAS No.: 2407457-23-0
Research Areas:  

Cancer

WDR5 ligand 4 is a WDR5 ligand. WDR5 ligand 4 can be used as a ligand for target protein for PROTAC in the synthesis of WDR5 PROTAC degraders. WDR5 ligand 4 can be coupled with the VHL ligand (S,R,S)-AHPC-Me (HY-112078) via linker to synthesize MS67 (HY-141796). WDR5 ligand 4 can be used in cancer research .
loading...
    loading...